In a new translational research study published in Cancer Research, investigators at Beth Israel Deaconess Medical Center (BIDMC) explored the potential of statins—commonly used medications for managing cholesterol levels—to work in conjunction with AKT inhibitors, a class of drugs that target a key pathway involved in cancer cell survival and...
Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype retrieved 5 August 2024 from https://medicalxpress.com/news/2024-08-combining-cholesterol-lowering-statins-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancerA research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty liver disease) exhibit excessive production of a hepatokine called Fibroblast Growth Factor 21 (FGF21) in their liver, which...
Read more »
Women at lower risk of breast cancer after ovarian cancer diagnosis, research suggestsWomen treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from Manchester University NHS Foundation Trust (MFT) and The University of Manchester has revealed.
Read more »
Combining popular diabetes drugs offers complementary heart and kidney benefits, research findsNew research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.
Read more »
Research uncovers hidden Australian skin cancer epidemicDeaths from non-melanoma skin cancers have almost doubled in Australia this millennium—and the culprit is hiding in plain sight, according to new medical research led by the University of the Sunshine Coast.
Read more »
Research identifies priority zones that may help improve colorectal cancer screening among Hispanic/Latino individualsCleveland Clinic-led research has identified geographic areas in the United States where strategic efforts to promote colorectal cancer screening could help reduce health care gaps affecting Hispanic/Latino communities.
Read more »
Treatment for recurrent uterine cancer advances to next research phaseThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves ahead to be studied further in a Phase III trial.
Read more »